Introduction: FOXO4-DRI peptide permits selective apoptosis of senescent cells, supports metabolic research, and ensures steadiness in exploration, improving reproducibility and advancing aging and oncology investigations. Daily laboratory workflows normally expose gaps where by present compounds fail to deal with mobile senescence comprehensively